Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

15.32
Delayed Data
As of Jul 31
 +1.06 / +7.43%
Today’s Change
10.58
Today|||52-Week Range
23.84
+8.27%
Year-to-Date

Today’s Trading

Previous close14.26
Today’s open14.24
Day’s range13.59 - 15.74
Volume1,707,314
Average volume (3 months)587,170
Market cap$1.9B
Dividend yield6.53%
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+90.11%
Earnings growth (next 5 years)-464.61%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.80+4.88%
PTCTPTC Therapeutics Inc+0.47+0.93%
MNKDMannkind Corp-0.17-3.81%
TTPHTetraphase Pharmaceu...-0.16-0.34%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts